KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Deferred Taxes (2020 - 2025)

Biolife Solutions (BLFS) has disclosed Deferred Taxes for 6 consecutive years, with $14000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Deferred Taxes rose 115.05% to $14000.0 in Q3 2025 year-over-year; TTM through Dec 2025 was $65000.0, a 201.56% increase, with the full-year FY2025 number at $65000.0, up 201.56% from a year prior.
  • Deferred Taxes was $14000.0 for Q3 2025 at Biolife Solutions, down from $45000.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $45000.0 in Q2 2025 to a low of -$12.6 million in Q2 2021.
  • A 5-year average of -$1.6 million and a median of -$95500.0 in 2023 define the central range for Deferred Taxes.
  • Biggest YoY gain for Deferred Taxes was 124.49% in 2024; the steepest drop was 504.35% in 2024.
  • Biolife Solutions' Deferred Taxes stood at -$2.6 million in 2021, then surged by 88.36% to -$301000.0 in 2022, then soared by 67.44% to -$98000.0 in 2023, then surged by 124.49% to $24000.0 in 2024, then crashed by 41.67% to $14000.0 in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Deferred Taxes are $14000.0 (Q3 2025), $45000.0 (Q2 2025), and $6000.0 (Q1 2025).